Skip to main content
. 2021 Dec 22;77(11):1131–1139. doi: 10.1136/thoraxjnl-2021-217190

Table 3.

Change in spirometry (completed to ATS standard) over the 3-year post-TB-treatment completion

Variable TB-treatment completion
N=285
1-year post-TB treatment completion N=292 2-year post-TB treatment completion N=293 3-year post TB-treatment completion
N=272
Mean change over 3 years (normalised to time) P value comparing TB-treatment completion and 3-year visit
Spirometry*
FVC z-Score, mean (SD) −0.91 (1.21) −0.61 (1.11) −0.55 (1.10) −0.64 (1.10) 0.28 (0.63) <0.0001
FEV1 z-score, mean (SD) −1.07 (1.24) −0.87 (1.18) −0.81 (1.15) −0.91 (1.16) 0.16 (0.59) <0.0001
FEV1/FVC ratio z-score, mean (SD) −0.38 (1.26) −0.52 (1.30) −0.56 (1.34) −0.56 (1.30) −0.19 (0.69) <0.0001
Reversible† 4 (1.25%) 7 (2.40%) 4 (1.37%) 1 (0.37%) 0.1800

*ATS standard spirometry n=285/319 at TB-treatment completion=292/319 at 1-year visit n=293/319 at 2-year visit, n=272/301 at the 3-year last visit.

†Reversible spirometry with an FEV1 change of 12%.

FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.